Search Prime Contracts

75F40124C00094

Definitive Contract

Overview

Government Description
DEVELOPING UNIVERSAL CONTROL PEPTIDES FOR T-CELL ASSAYS SUPPORTING IMMUNOGENICITY
Awardee
Cubrc
Awarding / Funding Agency
FDA Office of Acquisition and Grant Services (OAGS) [HHS - FDA]
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
H166 - Quality Control- Instruments And Laboratory Equipment
Place of Performance
Buffalo, NY 14225 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
6
Related Opportunity
None
Cubrc was awarded Definitive Contract 75F40124C00094 (75F401-24-C-00094) for Developing Universal Control Peptides For T-Cell Assays Supporting Immunogenicity worth up to $2,161,743 by the FDA Office of Acquisition and Grant Services in August 2024. The contract has a duration of 2 years 1 months and was awarded full & open with NAICS 541715 and PSC H166 via direct negotiation acquisition procedures with 1 bid received. As of today, the Definitive Contract has a total reported backlog of $1,147,743.

Status
(Open)

Last Modified 2/25/25
Period of Performance
8/16/24
Start Date
2/28/26
Current End Date
9/29/26
Potential End Date
33.0% Complete

Obligations and Backlog
$1.0M
Total Obligated
$1.0M
Current Award
$2.2M
Potential Award
47% Funded
$0.0
Funded Backlog
$1.1M
Total Backlog

Award Hierarchy

Definitive Contract

75F40124C00094

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75F40124C00094

Transaction History

Modifications to 75F40124C00094

People

Suggested agency contacts for 75F40124C00094

Competition

Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
M5T9V4YAGNM5
Awardee CAGE
8Y166
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhshilda_aryeh
Last Modified By
hhsian_weiss
Approved By
hhsian_weiss

Legislative

Legislative Mandates
None Applicable
Performance District
NY-26
Senators
Kirsten Gillibrand
Charles Schumer
Representative
Brian Higgins
Modified: 2/25/25